VANCOUVER, British Columbia, August 8, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pfizer (NYSE:PFE), Nu Skin (NYSE:NUS), McDermott International (NYSE:MDR), Arch Coal (NYSE:ACI), BroadSoft (NASDAQ:BSFT), and Applied Materials (NASDAQ:AMAT).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Pfizer Inc. (NYSE:PFE): On August 7, Pfizer Inc. (NYSE:PFE) announced that the company has signed a license agreement with Mylan Specialty L.P., a subsidiary of Mylan Inc. Under the terms of the agreement, Pfizer will obtain the exclusive rights to market and sell EpiPen® Injection 0.3/0.15mg in Japan. These products are for self-administration for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise or unknown triggers. EpiPen Injection is the only approved epinephrine auto-injector in Japan. The financial terms of the agreement were not completed. What's more, Pfizer stated on August 1 that Daniel L. Kisner, M.D. has been appointed to its Board of Directors. The election of Dr. Kisner increases the total number of Pfizer Directors to six. In the last trading session, share of Pfizer dumped 2.14% to US$23.74 on hefty volume of 56.37 million shares, above its usual volume of 37.53 million shares. Its price, as of the latest close, was up 42.8% compared with the 52-week low and was 3.2% below the 52-week high. Do you think now is a good time to buy or sell Pfizer? Do you want to know when Pfizer insiders will purchase their shares? See insider trade report for PFE here.
Read Full Report: http://www.insiderslab.com/PR3/080812A/PFE/Pfizer.pdf
Nu Skin Enterprises, Inc. (NYSE:NUS): Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) slumped 9.21% to US$44.36 in the last trading session after short-seller Citron Research published a report alleging that the personal-care products maker was operating an illegal multi-level marketing scheme in China. Citron, run by California-based investor and notable short-seller Andrew Left, alleged on its website Tuesday that Nu Skin's direct-selling business in China was actually "pyramid-selling" and was illegal under Chinese law. Nu Skin stated that its business model in China is differed from its global model, but said its compensation policies were similar to other direct selling companies operating in the country. By the end of July, Nu Skin showed second-quarter revenue was increased by 40% to US$593.2 million, from revenue of US$424.4 million a year ago. Abnormal trading volume of Nu Skin was found on August 7 reaching 13.54 million shares, 15 times heavier than usual day trading. Do you think the stock will rebound or continue to drop? Do you think now is a good time to sell the stock? Investors could get an idea by checking this insider trade report for NUS here.
Read Full Report: http://www.insiderslab.com/PR3/080812A/NUS/NuSkin.pdf
McDermott International (NYSE:MDR): McDermott International (NYSE:MDR) recently reported income from continuing operations of US$52.7 million, or US$0.22 per diluted share, for the second quarter of 2012, compared with continuing operations of US$63.7 million, or US$0.27 per diluted share, in the same quarter of 2011. During the latest quarter, McDermott International showed revenues were US$889.2 million compared to US$849.8 million, a year ago. There were 12.67 million stock shares traded, which was 3.9 times more than average volume. Did McDermott International insiders sell their shareholdings before the stock price dropped? Since insiders have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for MDR here.
Read Full Report: http://www.insiderslab.com/PR3/080812A/MDR/McDermottInternational.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Arch Coal Inc. (NYSE:ACI):
Read Full Report: http://www.insiderslab.com/PR3/080812A/ACI/ArchCoal.pdf
BroadSoft Inc. (NASDAQ:BSFT):
Read Full Report: http://www.insiderslab.com/PR3/080812A/BSFT/BroadSoft.pdf
Applied Materials, Inc. (NASDAQ:AMAT):
Read Full Report: http://www.insiderslab.com/PR3/080812A/AMAT/AppliedMaterials.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
